Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple immune system components
- Molecular classification
- Antibody (Immunoglobulin), Cytokine, Complement protein, Immune cell surface receptor (e.g., T-cell receptor, B-cell receptor, Fc receptor), Pattern recognition receptor (PRR, e.g., Toll-like receptors), Enzyme (e.g., lysozyme, collagenase), Cell adhesion molecule (e.g., clusters of differentiation/CD markers), Ion channels, transporters, and other signaling molecules (context-dependent)
01
Overview
Multiple immune system components" collectively refers to the diverse molecules and cell types that work in concert to defend against pathogens, maintain tissue homeostasis, regulate inflammation, and coordinate adaptive and innate immune responses. These include immunoglobulins (antibodies), cytokines, complement proteins, pattern recognition receptors, and cell-surface molecules found on lymphocytes, phagocytes, and other immune cells. They play roles in pathogen recognition, cell signaling, antigen presentation, cytotoxicity, and regulation of immune balance. Each component can serve as a therapeutic target and biomarker, but the term itself is too general to specify a single molecule, receptor, or precise pharmacological target.
- Other names
- immune componentsimmune system moleculesimmune cell typesimmune mediators
02
Mechanism of action
Block or activate cell surface receptors; Neutralize antibodies or cytokines; Enhance or inhibit leukocyte function; Inhibit complement activation; Target antigens for destruction
03
Biological functions
Pathogen recognition and eliminationSignal transductionAntigen presentationCell-mediated cytotoxicityRegulation of inflammationHumoral immunity (including antibody production)Immune surveillance (tumor, infection detection)Homeostasis of tissuesOther immune responses (anti-parasite, allergic, autoimmune)
04
Disease associations
InfectionCancer (immune surveillance, immune escape)Autoimmunity (e.g., type 1 diabetes, multiple sclerosis, Graves disease, myasthenia gravis)Allergy (IgE-mediated, Th2 response)InflammationImmunodeficiency (primary or acquired)Other (e.g., tissue homeostasis, Crohn's disease, ulcerative colitis)
05
Safety considerations
Immunosuppression and increased infection risk (from broadly targeting immune components)Cytokine release syndrome (on blockade or activation)Autoimmunity (activation of immune components)Allergic or hypersensitivity reactionsOff-target cytotoxicity
06
Interacting drugs
Monoclonal antibodies (against T-cell receptors, B-cell receptors, cytokines)
5 more in the full profile.
07
Biomarkers
Immunoglobulin levels (IgG, IgM, IgA, IgD, IgE)Cytokines (e.g., IL-6, IFN-gamma, TNF-alpha)CD markers (e.g., CD4, CD8, CD20)Complement proteins (C3, C4)Cell counts (lymphocytes, neutrophils, monocytes)
Beyond the preview
Go deeper on Multiple immune system components.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Multiple immune system components.